Beijing Tongren Hospital

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Phase 3 Study of Intravitreal 4D-150 in Adults With Diabetic Macular Edema (DME) (4D-150-C005)	eye disorder	Recruiting	Phase 3	2026-10-09	NCT07867080
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis	LGI1 Autoimmune Encephalitis; NMDAR Autoimmune Encephalitis	Active, not recruiting	Phase 3	2026-10-08	NCT05503264
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)	Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)	Recruiting	Phase 3	2026-10-07	NCT06338995
A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)	Neovascular Age-related Macular Degeneration; nAMD	Active, not recruiting	Phase 3	2026-09-01	NCT05562947

Clinical trials